PL3.02 - Next generation functional genomics: single cell CRISPR optimized approach for uncovering..

PL3.02 - Next generation functional genomics: single cell CRISPR optimized approach for uncovering..

by European Society of Human Genetics

Life & Natural Systems Biology PSALife sciences: general issuesPSAKGenetics (non-medical)
🎙 European Society of Human Genetics 👥 4K 📅 December 1, 2025 ⏱ 15 min 👁 76 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

CRISPR screensingle-cellcoronary artery diseasenon-coding variantscis-regulatory elements

Summary

Veronica Yumisba presents her PhD work on a next-generation functional genomics approach to uncover target genes of coronary artery disease (CAD) variants. She highlights the challenge of interpreting non-coding variants identified by GWAS, which constitute the majority of CAD-associated loci. To address this, she developed a high-throughput CRISPR screen using dead Cas9 (dCas9) fused to activation or interference domains, combined with single-cell RNA sequencing (scRNA-seq) as a readout. The approach allows testing hundreds of loci in a single experiment. She targeted 220 non-coding loci associated with CAD, using a library of 2,000 guide RNAs in monocytes and endothelial cells. Results showed that CRISPR activation and interference identified differentially expressed genes, often not the nearest gene to the variant, challenging the traditional dogma. Validation experiments using active Cas9 to delete candidate cis-regulatory elements confirmed some effects. The method offers advantages such as testing many loci at once and identifying cell-specific effects, but has limitations including off-target effects and complex data analysis. Future directions include applying the approach to other cell types and diseases.

172 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into a novel high-throughput method for functional annotation of non-coding variants. The argumentation is solid, based on experimental data and validation. The speaker clearly explains the rationale, methodology, and results, and acknowledges limitations. The work addresses a significant bottleneck in genomics and has potential broad applications.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with a clear experimental design, appropriate controls, and validation experiments. The speaker does not cite specific external sources, but the work is presented at a professional conference, indicating peer review. The title accurately reflects the content. No public comments were provided for analysis.

114 words

Title / Content Match

The title accurately reflects the content, focusing on a single-cell CRISPR approach for functional genomics in coronary artery disease.

Quality & Reliability

8/10

Presentation of original research with clear methodology, results, and validation. Limitations acknowledged. No external sources cited, but the work is presented at a professional conference.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Contribution & Novelties

The presentation introduces a high-throughput single-cell CRISPR screen for functional annotation of non-coding variants in coronary artery disease. This approach allows testing hundreds of loci in a single experiment, identifying cell-specific effects and target genes, and challenging the nearest-gene dogma. The validation with active Cas9 adds robustness. This method has potential for broader application in complex trait genetics.

Pour aller plus loin :

96 words

Radar Profile

The radar profile shows high scores across all dimensions, indicating a well-rounded and reliable presentation. The balance between technical depth and clarity suggests the content is both rigorous and accessible to a specialized audience.

Reliability 8/10